Montana Senate Passes Bill to Expand Right to Try Act; Further Reject Some FDA Restrictions on Experimental Treatments
The enactment of SB422 would expand the law to enable any patient to access medications and treatments not yet given final approval for use by the FDA. SB422 would simply remove all patient eligibility requirements from the current law.
The post Montana Senate Passes Bill to Expand Right to Try Act; Further Reject Some FDA Restrictions on Experimental Treatments first appeared on Tenth Amendment Center.